Orient Europharma Co Ltd Total Liabilities
Orient Europharma Co Ltd total liabilities. Based on the latest financial reports, Orient Europharma Co Ltd (4120) has total liabilities worth NT$4.54 Billion TWD (≈ $142.94 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 4120 financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Orient Europharma Co Ltd (2015–2024)
Total liabilities of Orient Europharma Co Ltd from 2015 to 2024. This chart illustrates how Orient Europharma Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Orient Europharma Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Orient Europharma Co Ltd Competitors by Total Liabilities
The table below lists competitors of Orient Europharma Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Harvest Minerals Ltd
LSE:HMI
|
UK | GBX4.56 Million |
|
Mothercare PLC
LSE:MTC
|
UK | GBX36.40 Million |
|
Alpine 4 Holdings Inc
NASDAQ:ALPP
|
USA | $83.91 Million |
|
MingZhu Logistics Holdings Ltd
NASDAQ:YGMZF
|
USA | $22.99 Million |
|
Hornby PLC
LSE:HRN
|
UK | GBX30.80 Million |
|
Eos Energy Enterprises Inc
NASDAQ:EOSEW
|
USA | $2.65 Billion |
|
Adomos SA
PA:ALADO
|
France | €11.25 Million |
|
Bolt Projects Holdings, Inc.
NASDAQ:BSLK
|
USA | $23.88 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Orient Europharma Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 4120 current and non-current assets.
Liquidity & Leverage Metrics
Orient Europharma Co Ltd Total Liabilities Ratios Explained
Orient Europharma Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.65 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.66 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.37 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Orient Europharma Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Orient Europharma Co Ltd (2015–2024)
The table below shows the annual total liabilities of Orient Europharma Co Ltd from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$5.75 Billion ≈ $181.03 Million |
-13.59% |
| 2023-12-31 | NT$6.65 Billion ≈ $209.49 Million |
-4.83% |
| 2022-12-31 | NT$6.99 Billion ≈ $220.11 Million |
+17.41% |
| 2021-12-31 | NT$5.95 Billion ≈ $187.47 Million |
+39.86% |
| 2020-12-31 | NT$4.25 Billion ≈ $134.04 Million |
+4.77% |
| 2019-12-31 | NT$4.06 Billion ≈ $127.94 Million |
+31.11% |
| 2018-12-31 | NT$3.10 Billion ≈ $97.58 Million |
+21.19% |
| 2017-12-31 | NT$2.56 Billion ≈ $80.52 Million |
-0.56% |
| 2016-12-31 | NT$2.57 Billion ≈ $80.98 Million |
+22.98% |
| 2015-12-31 | NT$2.09 Billion ≈ $65.84 Million |
-- |
About Orient Europharma Co Ltd
Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk under the Karihome brand name; and healthcare supplement… Read more